Gabapentin: A new tool in the treatment of neuropathic pain

Acta Neurologica Scandinavica, Supplement

Volumn 100, Issue 173, 1999, Pages 43-47

  Harden, R Norman ^a  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

Diabetic peripheral neuropathy; Gabapentin; Neuropathic pain; Postherpetic neuralgia

Indexed keywords

GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT; 4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ANALGESIA; CLINICAL TRIAL; DRUG TOLERABILITY; ELDERLY CARE; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTICENTER STUDY; NEUROPATHY; PAIN; RATING SCALE; RELIABILITY; REVIEW; TREATMENT OUTCOME; DOSE RESPONSE; DRUG ADMINISTRATION; NEURALGIA;

ACETIC ACIDS; AMINES; CLINICAL TRIALS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA; TREATMENT OUTCOME;

EID: 0032825398     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb07389.x     Document Type: Review

References (40)

1. 1. FIELDS HL. Peripheral neuropathic pain: an approach to management. In: WALL PD, MELZACK R, eds. Textbook of pain, 3rd ed. New York: Churchill Livingstone, 1994: 991-6.
2. 2. PORTENOY RK. Painful neuropathy. Neurol Clin 1989: 2: 283.
3. 3. TURK D. Biopsychosocial perspectives on chronic pain. In: GATCHEL RJ, TURK DC, eds. Psychological approaches to pain management. New York: The Guilford Press, 1996:3-32.
4. 4. LICHT S, ed. Therapeutic heat and cold, 2nd ed. Baltimore: Waverly Press, 1965.
5. 5. MEYERSON BA. Electrostimulation procedures: effects, presumed rationale, and possible mechanisms. In: BONICA JJ, LINDBLOM U, IGGO A, eds. Advances in pain research and therapy. Vol. 5. New York: Raven Press, 1983: 495-534.
6. 6. WOOLF CJ, THOMPSON JW. Stimulation-induced analgesia: transcutaneous electrical nerve stimulation (TENS) and vibration. In: WALL PD, MELZACK R, eds. Textbook of pain, 3rd ed. New York: Churchill Livingstone, 1994: 1191-1208.
7. 7. BRADLEY LA. Cognitive-behavioral therapy for chronic-pain. In: GATCHEL RJ, TURK DC, eds. Psychological approaches to pain management: A practitioner's handbook. New York: The Guilford Press, 1996:131-147.
8. 8. GRABOIS M. Treatment of pain syndromes through exercise. In: LOWENTHAL DT, BHARADWAJA K, OAKS W, eds. Therapeutics through exercise. New York: Grune & Stratton, 1979: 181-5.
9. 9. ARENA JG, BLANCHARD EB. Biofeedback and relaxation therapy for chronic pain disorders. In: GATCHEL RJ, TURK DC, eds. Psychological approaches to pain management: A practitioner's handbook. New York: The Guilford Press, 1996: 179-230.
10. 10. BONICA JJ. Multidisciplinary/interdisciplinary pain programs. In: BONICA JJ, LOESER JD, CHAPMAN CR, FORDYCE W, eds. The management of pain, 2nd ed. Philadelphia: Lea & Feibiger, 1990: 197-208.
11. 11. LEE MHM, ITOH M, YANG GW, EASO AL. Physical therapy and rehabilitation medicine. In: BONICA JJ, LOESER JD, CHAPMAN CR, FORDYCE W, eds. The management of pain, 2nd ed. Philadelphia: Lea & Feibiger, 1990: 1769-88.
12. 12. BRENA SF. Pain control facilities: roots, organization, and function. In: BRENA SF, CHAPMAN R, eds. Management of patients with chronic pain. Jamaica, NY: Spectrum Publications, Inc., 1983: 11-20.
13. 13. BOWSHER D. Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom Manage 1996: 12: 290-9.
14. 14. KINGERLY WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997: 73: 123-39.
15. 15. VOLMINK J, LANCASTER T, GRAY S, SILAGY C. Treatments for postherpetic neuralgia a systematic review of randomized controlled trials. Fam Pract 1996: 13: 84-91.
16. 16. MAX MB. Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 1995: 4: 248-53.
17. 17. KISHORE-KUMAR R, MAX MB, SCHAFER SC et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990: 47: 305-12.
18. 18. WATSON CP, CHIPMAN M, REED K, EVANS RJ, BIRKETT N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992: 48: 29-36.
19. 19. WATSON CPN, EVANS RJ, REED K, MERSKEY H, GOLDSMITH L, WARSH J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982: 32: 671-3.
20. 20. TAKEDA Y, KOBAYASHI H, SUZUKI K, SEI Y, NISHIO K, ISHIZAKI H. Analgesic effects of clomipramine (Anafranil) on postherpetic neuralgia. Skin Res 1988: 30: 33-6.
21. 21. MAX MB, SCHAFER SC, CULNANE BSN, SMOLLER B, DUBNER R, GRACELY RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988: 38: 1427-32.
22. 22. MCQUAY H, CARROLL D, JADAD AR, WIFFEN P, MOORE A. Anticonvulsant drugs for management of pain: a systematic review. Br Med J 1995: 311: 1047-52.
23. 23. WATSON CPN. The treatment of postherpetic neuralgia. Neurology 1995: 45 (suppl 8): S58-60.
24. 24. WATSON CPN, TYLER KL, BICKERS DR, MILLIKAN LE, SMITH S, COLEMAN E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993: 15: 510-26.
25. 25. HARDEN RN, BRUEHL S, SIEGLER J, COLE PA. Pain, psychological status, and functional recovery in chronic pain patients on daily opioids: a case comparison. J Back Musculoskel Rehab 1997: 9: 101-8.
26. 26. HARDEN RN, BRUEHL S. Point/counterpoint. The use of opioids in the treatment of chronic pain: an examination of the ongoing controversy. J Back Musculoskel Rehab 1997: 9: 155-80.
27. 27. WATSON CP, BABUL N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998: 50: 1837-41.
28. 28. HARATI Y, GOOCH C, SWENSON M et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998: 50: 1842-46.
29. 29. GOA KL, SORKIN EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs 1993: 46: 409-27.
30. 30. ATTAL N, PARKER F, BRASSEUR L, CHAUVIN M, BOUHASSIRA D. Effects of gabapentin on the different components of neuropathic pain syndromes: a pilot study. Europ Neurol 1998: 40: 191-200.
31. 31. MELLICK GA, MELLICY LB, MELLICY LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995: 10: 265-6.
32. 32. ROSNER H, RUBIN L, KESTENBAUM A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996: 12: 56-8.
33. 33. SUMAN-CHAUMAN N, WEBDALE L, HILL DR, WOODRUFF GN. Characterization of 3H gabapentin binding to a novel site in the rat brain: homogenate binding studies. Eur J Pharmacol 1993: 244: 293-301.
34. 34. STEFANI A, SPADONI F, BERNARDI G. Gabapentin inhibits calcium currents in rat brain neurons. Neuropharmacology 1998: 37: 83-91.
35. 35. GILLIN S, SORKIN LS. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug. Anesth Analg 1998: 86: 111-16.
36. 36. HWANG JH, YAKSH TL. The effect of gabapentin on tactile-evoked allodynia in a surgically-induced neuropathic pain model in the rat. Reg Anesthesia 1997: 77: 749-56.
37. 37. XIAO WH, BENNETT GJ. Gabapentin relieves abnormal pain sensations via a spinal site of action in a rat model of painful peripheral neuropathy. Analgesia 1996: 2: 267-73.
38. 38. HUNTER JC, GOGAS KR, HEDLEY LR et al. The effect of novel antiepileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997: 324: 153-60.
39. 39. ROWBOTHAM M, HARDEN N, STACEY B et al. Gabapentin for the treatment of postherpetic neuralgia: a multicenter double-blind, placebo-controlled study. JAMA 1998: 280: 1837-42.
40. 40. BACKONJA M, BEYDOUN A, EDWARDS KR et al. Gabapentin monotherapy for the treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. JAMA 1998: 280: 1831-36.